Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2008
11/18/2008US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
11/18/2008US7452881 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide; serotonin receptors antagonist; anxiolytic, antidepressant, cognitive activator, senile dementia, psychosis, attention deficit/hyperactivity disorder
11/18/2008US7452880 p38 kinase inhibitors; arthritis, Crohn's disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease; pyrazolo(3,4-d)pyrimidines
11/18/2008US7452879 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/18/2008CA2516557C Triazole compounds useful in therapy
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2352275C Il-5 inhibiting 6-azauracil derivatives
11/18/2008CA2331187C Water soluble azoles as broad-spectrum antifungals
11/18/2008CA2278331C 3-heterocyclyl-substituted benzoyl derivatives
11/18/2008CA2230516C Pyrimidine derivatives
11/13/2008WO2008137435A1 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/13/2008WO2008137139A1 Gamma secretase modulators
11/13/2008WO2008136428A1 Nitrogen-containing five-membered heterocyclic compound
11/13/2008WO2008136279A1 Salt of heterocycle-substituted pyridine derivative or crystal thereof
11/13/2008WO2008135830A1 N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
11/13/2008WO2008135181A2 Insecticidal substituted 2-aminoindanes
11/13/2008WO2008115369A3 Inhibitors of focal adhesion kinase
11/13/2008WO2008114023A3 Phthalazinone derivatives
11/13/2008WO2008065500A3 Heteroaryl amides as type i glycine transport inhibitors
11/13/2008WO2007145563A8 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
11/13/2008US20080281111 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/13/2008US20080280977 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/13/2008US20080280973 Laulimalide Analogues as Therapeutic Agents
11/13/2008US20080280925 Amines as Small Molecule Inhibitors
11/13/2008US20080280919 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
11/13/2008US20080280911 Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4)
11/13/2008US20080280907 Triazolophthalazines
11/13/2008US20080280906 Imidazolyl-Pyrimidine Compounds for Use in the Treatment of Proliferative Disorders
11/13/2008US20080280905 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
11/13/2008US20080280904 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors
11/13/2008US20080280903 antiapoptosis agents such as 1-[2-Methoxyimino-2-(4-pyrrolidin-1-yl-phenyl)-ethyl]-quinolinium bromide, used for cytoprotection or for side effect reduction of anticarcinogenic agents
11/13/2008US20080280902 Inhibitors of Checkpoint Kinases
11/13/2008US20080280899 Cancer; such as 3-({4-[2-(methylthio)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]benzyl}amino)-1-phenylpropan-1-one; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity
11/13/2008US20080280896 Dipyrrole Compounds, Compositions, and Methods For Treating Cancer or Viral Diseases
11/13/2008US20080280891 effective against a broad range of cancers, especially leukemia, non-small cell lung and colon; (6-chloropyridin-3-yl)-[3-hydroxy-5-(1H-indol-4-yl)-phenyl]-methanone; antimitotic agents that can block cell cycle progression
11/13/2008US20080280890 Hydroxylamine compounds and methods of their use
11/13/2008US20080280889 Cancer; N,N-dimethyl-5-phenyl-6-(4-{[4-(5-pyridin-2-yl-1H-pyrazol-3-yl)piperidin-1-yl]methyl}phenyl) pyridazin-3-amine;; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties
11/13/2008US20080280887 Selected Cgrp-Antagonists, Processes for Preparing Them and Their Use as Pharmaceutical Compositions
11/13/2008US20080280881 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
11/13/2008US20080280876 Sphingosine-1-phosphate (S1P) receptor agonists or antagonists; immunosuppressants; e.g. 3-(3-chloro-4-isopropoxyphenyl)-5-(p-(3-carboxyazetidin-1-ylmethyl)phenyl)-1,2,4-oxadiazole; two specific compounds are excluded
11/13/2008US20080280873 Biaryl Substituted Pyrazinones as Sodium Channel Blockers
11/13/2008US20080280872 Benzamide Derivatives and Their Use as Glucokinase Activating Agents
11/13/2008US20080280857 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
11/13/2008US20080279867 Prevent trabsplant rejection; autoimmune diseases
11/13/2008CA2686589A1 Gamma secretase modulators
11/13/2008CA2685389A1 Tricyclic compounds as matrix metalloproteinase inhibitors
11/13/2008CA2685194A1 Heterocycle-substituted pyridine derivatives salt or crystal thereof
11/12/2008EP1990338A2 Biphenylcyclopropylamides as p-38 Kinase inhibitors
11/12/2008EP1990335A1 17 beta hsd type 5 inhibitor
11/12/2008EP1989198A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders
11/12/2008EP1989195A1 Phosphodiesterase 10 inhibitors
11/12/2008EP1912976B1 Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as v1a receptor antagonists
11/12/2008EP1863474B1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
11/12/2008EP1705989B1 Substituted arylpyrazoles as parasiticidal agents
11/12/2008EP1703905B1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
11/12/2008EP1606282B1 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
11/12/2008EP1315490B1 A method for treating allergies using substituted pyrazoles
11/12/2008CN101304996A Pyrimidine derivatives for the inhibition of IGF-1R tyrosine kinase activity
11/12/2008CN101304994A 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
11/12/2008CN101304993A Compounds and compositions as ppar modulators
11/12/2008CN101304992A 1, 3-disubstituted indole derivatives for use as PPAR modulators
11/12/2008CN101304989A Carbocyclic fused cyclic amines as inhibitors of the coagulation factor XA
11/12/2008CN101304982A Process for the preparation of benzotriazepine derivatives
11/12/2008CN101304976A Inhibitors of viral replication
11/12/2008CN101304973A Methods of modulating neurotrophin-mediated activity
11/12/2008CN101302214A Aralkyl piperidine (piperazidine) derivate and use thereof in mental disease treatment
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN101302180A 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
11/12/2008CN100432064C Preparation of taxus alkane derivative
11/12/2008CN100432059C Quinazolinone derivatives useful as anti-hyperalgesic agents
11/11/2008US7449583 Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine)
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449464 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
11/11/2008US7449463 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
11/11/2008US7449459 Inhibitors of soluble adenylate cyclase
11/11/2008US7449457 Substituted heterocyclic carboxamides with antithrombotic activity
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/06/2008WO2008133955A1 6-phenylpyrimidinones as pim modulators
11/06/2008WO2008133155A1 Bicyclic heterocyclic compound
11/06/2008WO2008132679A1 Bridged six-membered ring compounds
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008WO2008131860A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2008073933A3 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
11/06/2008US20080275224 Cyanoborate, Fluoroalkylphosphate, Fluoroalkylborate or Imide Dyes
11/06/2008US20080275093 Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]-, (4-methyl-5-oxido-1,2,5-oxadiazol-3-yl)methyl ester; oxatriazole-5-ones and/or oxatriazole-5-imines etc. are linked to the diuretic compounds through one or more sites such as O, N, S; cardiovascular, diabetes, oxidatives stress
11/06/2008US20080275092 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/06/2008US20080275090 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/06/2008US20080275066 3-Methanesulfonyl-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylic acid 2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl ester; for treatment of metabolic disorders such as IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity
11/06/2008US20080275061 Method for controlling particular insect pests by applying anthranilamide compounds
11/06/2008US20080275046 1-(3-{4-[4-(piperidin-1-ylmethyl)-1,3-oxazol-2-yl]phenoxy}propyl)piperidine; 4,4-difluoro-1-[(4-methyl-2-{4-[3-(2-methylpyrrolidin-1-yl)propoxy]phenyl}-1,3-thiazol-5-yl)carbonyl]piperidine; histamine H3-receptor antagonists; Parkinson's and Alzheimer's diseases; sleep disorders; antiepileptics
11/06/2008US20080275045 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
11/06/2008US20080275044 Vanilloid receptor 1 antagonists; reducing a phenyl or 3-pyridyl carboxylic acid or ester to an alcohol, aziding, reduction to a primary amine, amidation with a (3-fluoro-4-methylsulfonamido)phenyl acetic acid; 2-(3-Fluoro-4-(methylsulfonamido)phenyl)-N-(substituted phenyl or pyrid-3-yl) acetamides
11/06/2008US20080275043 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1
11/06/2008US20080275042 4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility
11/06/2008US20080275041 3-[5-({4-[2-(Dipropylamino)ethyl]piperazin-1-yl}sulfonyl)pyridin-2-yl]-2-hydroxy-1H-indole-6-carbonitrile hydrochloride; Alzheimer's Disease, Parkinson's Disease, depression, schizophrenia, HIV, Down syndrome, bone disorders, alopecia
11/06/2008US20080275040 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders
11/06/2008US20080275029 Compounds for Treating Protein-Kinase Mediated Disorders
11/06/2008US20080275027 Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 647